secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001171843-25-007918
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech increases ATM offering capacity to $2.26M; discloses prior sales of $3.72M
--------------------------------------------------------------------------------

- Prospectus supplement filed to increase max aggregate offering under ATM to $2,262,508.
- Prior sales: $3.72M under Sept 2025 prospectus and $837K under Oct 2024 supplement.
- Legal opinion of Fasken Martineau DuMoulin LLP regarding validity of shares attached.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000117184325007918/0001171843-25-007918-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000117184325007918/f8k_121225.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007918

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer